Date: Monday, Sep 14, 2020
Description: Dr Jones describes the impact COVID-19 has on tick borne disease, including the impact of social distancing, explains the overlapping and the clinical utilization and algorithms for polymerase chain symptoms reaction (PCR) antibody testing to identify tick borne diseases, and identify the Lyme disease antibody with reflex to immunoassay (IgG, IgM) test. He also discusses the test utilization in conjunction with the updated Center for Disease Control guidelines for the serological diagnosis of Lyme disease.
At the conclusion of this program, participants will be able to:
Describe the impact COVID-19 has on tick borne disease, including the impact of social distancing
Explain the overlapping symptoms and the clinical utilization and algorithms for polymerase chain reaction (PCR) antibody testing to identify tick borne diseases
Identify the Lyme disease antibody with reflex to immunoassay (IgG, IgM) test
Discuss test utilization in conjunction with the updated Center for Disease Controls guidelines for the serological diagnosis of Lyme disease
Authors:
Jones, Robert S., DO, MS, FACP, FIDSA, CPE
Associate Medical Director
Medical Director Infectious Diseases
Quest Diagnostics
Kapoor, Hema, MD SM, D(ABMM)
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey
